Statement of Retraction: MYCN contributes to the sensitization of acute myelogenous leukemia cells to cisplatin by targeting SRY-box transcription factor 4.

IF 4.2 4区生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Bioengineered Pub Date : 2024-12-01 Epub Date: 2024-02-01 DOI:10.1080/21655979.2024.2302650

引用次数: 0

查看原文本刊更多论文

撤回声明：MYCN 通过靶向 SRY-box 转录因子 4 使急性髓性白血病细胞对顺铂敏感。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Bioengineered BIOTECHNOLOGY & APPLIED MICROBIOLOGY-

CiteScore

8.20

自引率

28.60%

发文量

1114

审稿时长

17 weeks

期刊介绍： Bioengineered provides a platform for publishing high quality research on any aspect of genetic engineering which involves the generation of recombinant strains (both prokaryote and eukaryote) for beneficial applications in food, medicine, industry, environment and bio-defense.